Stockreport

Vermillion, Inc. and Einstein Medical Center Philadelphia Announce the First Patient Enrolled in Prospective National Clinical Study of Ovarian Cancer Risk Detection Methods in African Ame...

VERMILLION  (VRML) 
PDF Study evaluates the differences in sensitivity of ovarian cancer risk detection between OVA1® Plus and CA125 AUSTIN, Texas & PHILADELPHIA--(BUSINESS WIRE)--Vermillion [Read more]